CCR News Archives
CCR News Archives
2022
- Clinical trials research immunotherapy for Kaposi sarcoma
- In Memoriam: Joost J. Oppenheim, M.D. (1934–2022)
- Four CCR researchers receive high honors
- Elaine S. Jaffe receives HHS Career Achievement Award
- Clinical trial researching PSMA imaging in prostate cancer
- Computational model finds signatures of T cell resilience in solid tumors
- Clinical trial researching therapy for some small cell lung cancers
- Kandice Tanner receives Arthur S. Flemming Award
- Clinical trial researches therapy for VEXAS syndrome
- Protein signature in the blood linked to prostate cancer lethality in men of African ancestry
- Clinical trial researches three-part immunotherapy regimen for gastric or head and neck cancer
- CCR scientists to present at 2022 AACR Annual Meeting in New Orleans
- Clinical trial aims to reduce hormone therapy side effects for people with prostate cancer
- New Milestones publication now available
- First-in-human clinical trial evaluates drug for pancreatic cancer and other solid tumors
- Steven Pavletic named Top Ten Clinical Research Achievement awardee
- Clinical trial studies combination therapy for relapsed/refractory B-cell lymphomas
- Following the fellowship experience with CCR fellow Martha Teke, M.D.
- Following the fellowship experience with CCR fellow Bailey Johnson
- Clinical trial evaluates drug for treatment of neurofibromatosis type 1 and atypical neurofibromas
- Clinical trial compares interval dosing of two immune checkpoint inhibitors
- Unique gene expression profiles identify rare T cells that could be effective in cancer immunotherapy
- NCI study advances personalized immunotherapy for metastatic breast cancer
- Researchers develop new method to estimate cell-type-specific information from bulk tumor data
2021
- Breast cancer stem cells become aggressive upon contact with macrophages
- A high-fiber diet may improve the response of melanoma patients to immunotherapy
- Cell surface molecule could predict how patients respond to immunotherapy
- Clinical trial researches drug combination with immunotherapy for mesothelioma
- Clinical trial targets cell surface protein GPC3 to treat advanced hepatocellular carcinoma
- CCR researchers use immunogenetic profiling to identify targets for numerous pediatric cancers
- Anish Thomas explains the challenges and goals of his small cell lung cancer research
- Ibrutinib improves survival for younger people with diffuse large B-cell lymphoma
- Clinical trial studies breast cancer drug abemaciclib as a therapy for Kaposi sarcoma
- Rosenberg, Waldmann named 2021 Fellows of the Academy of Immuno-Oncology
- Gut bacteria sculpt innate immunity within the tumor microenvironment
- A conversation with Hunter Lab members about the Deaf Student Training Program
- Clinical trial evaluates new combination therapy for virus-associated malignancies
- In Memoriam: Thomas A. Waldmann, M.D. (1930-2021)
- New tool helps researchers make sense of complex immune signals
- Newly developed gel can be used to treat cancers that form on organ surfaces
- Clinical trial studies targeted therapy for PARP-resistant tumors and chemotherapy-resistant small cell lung cancer
- Immunotherapy studied in clinical trial for glioblastoma or gliosarcoma
- Clinical trial evaluates reduced dosing of cyclophosphamide to prevent severe acute graft-versus-host disease
- Sandra L. Wolin receives Sandra K. Masur Senior Leadership Award
- Clinical trial evaluates the effect of Minnelide on advanced pancreatic cancer
- Samira M. Sadowski discusses her work at CCR and offers advice for future cancer researchers
- Clinical trial studies surgical treatment for adults with peritoneal carcinomatosis
- Blood test reveals when benign NF1 tumors turn cancerous
- FDA approves belzutifan, first drug for cancers associated with von Hippel-Lindau disease
- New study tests drug combination for treatment of biliary tract cancer
- Clinical trial investigates drug combination for relapsed small cell lung cancers and advanced neuroendocrine cancers
- Clinical trial will test triple-drug combination against aggressive colon and HPV-associated cancers
- Steven A. Rosenberg and Louis M. Staudt receive HHS Departmental Awards
- Collaborative study leads to FDA approval of belumosudil for chronic graft-versus-host disease
- Clinical trial studies six-drug combination aimed at relapsed/refractory B-cell lymphoma
- Sheue-yann Cheng receives 2021 Valerie Anne Galton Lectureship Award
- Protein that drives aggressive liver cancer identified
- A conversation with Troy A. McEachron, Ph.D.
- Immune cells promote breast cancer’s metastasis to the brain in young mice
- International study of rhabdomyosarcoma finds genetic clues, potential for tailored therapy
- New study tests therapy in patients with hemorrhagic cystitis after bone marrow transplant
- Howard A. Young receives 2021 ICIS Mentorship Award
- Clinical trial studies immunotherapy and radiation for pancreatic cancer
- CCR postbaccalaureate fellow awarded Fulbright to study cancer disparities in Nigeria
- A conversation with CCR immunotherapy experts
- Vassiliki Saloura receives 2021 Conquer Cancer Foundation of ASCO Career Development Award
- CCR fellow receives 2021 Conquer Cancer Foundation of ASCO Young Investigator Award
- William Figg receives 2021 ACCP Distinguished Investigator Award
- AACR Annual Meeting - Session II
- Live-cell imaging reveals variability in RNA processing
- Elaine S. Jaffe to receive 2022 Gold-Headed Cane Award from the American Society for Investigative Pathology
- Steven A. Rosenberg named 2021 Dan David Prize laureate
- Brigitte C. Widemann selected as a 2021 Sammies finalist
- Clinical trial evaluates COVID-19 vaccine in adults in treatment for cancer
- Personalized approach to prostate cancer diagnosis could mean less invasive biopsies
- Vinay K. Pathak receives Cozzarelli Prize
- New fluorescent probes developed that can help clinicians pinpoint cancer metastases
- Stem cell transplant after CAR T-cell therapy effective for young leukemia patients
- FDA approves BCMA-targeted CAR T-cell therapy for multiple myeloma
- In Memoriam: George Vande Woude, Ph.D. (1935-2021)
- New tool predicts which treatments may work best in cancer patients
- CCR scientists and alumni honored by the American Association for Cancer Research
- Drug combination leads to durable responses in patients with small cell lung cancer
- Brigitte Widemann named a Top Ten Clinical Research Achievement Awardee
- Engineered myeloid cells have promise as a potential treatment for metastatic cancer
- Anish Thomas featured in The Cancer Letter for SCLC study
- FDA grants orphan drug designation to PRGN-2012 for recurrent respiratory papillomatosis
- Curtis C. Harris elected as a fellow of the AACR Academy
- Combination therapy in patients with advanced kidney cancer found to be highly effective
- Hotspots for DNA damage and repair in neurons identified
- Clinical trial investigates vaccine to treat recurrent respiratory papillomatosis after surgery
- New trial evaluates immunotherapy combinations in adults with advanced small bowel and colorectal cancers
- New Milestones publication now available
- Clinical trial evaluates combination therapy for men with metastatic prostate cancer
- New finding reveals how some cancers gain or lose chromosomes
- Drug lessens symptoms of severe chronic graft-versus-host disease
- A key mechanism that fuels uncontrolled cell growth is uncovered in yeast
- Registration and abstract submission now open for RNA Biology Symposium
- Potential therapeutic target for lung squamous cell carcinoma identified
- Clinical trial studies immunotherapy combination for recurrent thymoma and thymic carcinoma